Written by two expert oncologists, specializing in female cancers, Dx/Rx: Gynecologic Cancer is a perfect pocket reference for all professionals involved in the care of women with gynecologic cancer. This handy, 136-page book provides comprehensive, up-to-date information on the epidemiology, symptoms, diagnosis, and management of malignancies of the ovaries, cervix, uterus, and fallopian tubes. Topics include a review of gynecologic tumors, detailed analysis on treatment strategies, and a discussion of past and current literature that has shaped the field. Presented in a concise, quick-reference format, Dx/Rx: Gynecologic Cancer is an essential guide for the care of women with malignancies of the reproductive system.

Tightly organized into a super-condensed outline bulleted format, this handy, pocket-sized manual details precise, up-to-date information for diagnosis and treatment of cervical cancer and includes information on new vaccines. Throughout the book, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information. Dx/Rx: Cervical Cancer, Second Edition features current, quick, and concise information for instant access on the ward or in the clinic!

Dx/Rx: Liver Cancer is a quick and practical reference guide containing all aspects of the diagnosis and therapy of hepatocellular carcinoma (HCC), prognostic and staging systems, clinical management, molecular biology, current controversies, and future insights. Organized into a condensed, bulleted format, this concise reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the liver. Presented in a handy, easy-to-read format, Dx/Rx: Liver Cancer is a must-have resource for oncologists, internists, primary care physicians, and other health care professionals on the ward or in the clinic.

Written by a medical oncologist, Dx/Rx Melanoma is ideal for medical trainees, general practitioners, dermatologists, and medical oncologists. This handy, pocket-sized book provides comprehensive, up-to-date information on the epidemiology, prevention, and management of melanoma of all stages. It includes an in-depth discussion of systemic treatment options in both the adjuvant and metastatic setting, as well as, a look at novel treatment options. Presented in a concise, easy-to-read format, this is an essential reference for on the ward or in the clinic! Key features include: Written by a medical oncologist with a thorough discussion of systemic therapy of melanoma In-depth look at novel treatments being developed for advanced melanoma, including a discussion of all major recent studies Discussion of the molecular biology of melanoma and the treatment implications

Completely revised and updated for 2015, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers. SPECIAL FEATURES: -Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like afatinib, ceritinib, ibrutinib, idelalisib, obinutuzumab, and ramucirumab. -A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. -Diagrams of drug structures and pathways for many of the agents. -Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. -Covers toxicity and drug-drug interactions. -A section on chemotherapy regimens for all major cancers. -Provides an overview of the basic principles of cancer drug therapy.

Written by world-class experts in clinical cancer therapeutics, Physicians’ Cancer Chemotherapy Drug Manual 2017 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.